HB 6604 — AN ACT EXPANDING THE BREAST AND CERVICAL CANCER EARLY DETECTION AND TREATMENT REFERRAL PROGRAM TO INCLUDE LUNG CANCER SCREENING.

House of Representatives General Assembly FileSubstitute Bill No.

736604 January Session, 2023 SubstituteAN HouseACT BillEXPANDING No.THE BREAST AND CERVICAL CANCER EARLY DETECTION AND TREATMENT REFERRAL PROGRAM TO INCLUDE LUNG CANCER SCREENING.

6604 House of Representatives, March 15, 2023 The Committee on Public Health reported through REP.

MCCARTHY VAHEY of the 133rd Dist., Chairperson of the Committee on the part of the House, that the substitute bill ought to pass.

AN ACT EXPANDING THE BREAST AND CERVICAL CANCER EARLY DETECTION AND TREATMENT REFERRAL PROGRAM TO INCLUDE LUNG CANCER SCREENING.

(2) "Cervical cancer screening and referral services" means necessary cervical cancer screening services and referral services for a procedure intended to treat cancer of the human cervix, including, but not limited sHB6604to, /surgery, Fileradiation No.therapy, cryotherapy, electrocoagulation and related medical follow-up services.

73(3) 1"Lung sHB6604cancer Filescreening and referral services" means necessary lung cancer screening services and referral services for a procedure intended to treat cancer of the human lung, including, but not limited LCO \\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06604-R021 of 4 HB.docx Substitute Bill No.

736604 to, surgery, radiation therapy, cryotherapy,chemotherapy, electrocoagulationimmunotherapy and related medical follow-up services.

(3) "Lung cancer screening and referral services" means necessary lung cancer screening services and referral services for a procedure intended to treat cancer of the human lung, including, but not limited to, surgery, radiation therapy, chemotherapy, immunotherapy and related medical follow-up services.

(B) the benefits of early detection of breast cancer and the recommended frequency of screening services, including clinical breast sHB6604examinations /and Filemammography, No.which shall include, where possible, tomosynthesis;

73 2 sHB6604 File No.

73 examinations and mammography, which shall include, where possible, tomosynthesis;

and (D) the benefits of early detection of lungLCO cancer{\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-066042 andof the4 recommendedR02-HB.docx frequency} ofSubstitute screeningBill services;No.

6604 lung cancer and the recommended frequency of screening services;

sHB6604This /act Fileshall No.take effect as follows and shall amend the following sections:

73Section 1 October 1, 2023 19a-266 LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06604- 3 sHB6604of File4 R02-HB.docx } Substitute Bill No.

736604 ThisPH actJoint shallFavorable takeSubst. effect as follows and shall amend the following sections:

Section-LCO 1APP OctoberJoint 1,Favorable 2023LCO 19a-266{\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06604- Statement4 of Legislative4 Commissioners:R02-HB.docx }

In Subsection (c)(1)(D), "breast cancer" was changed to "lung cancer" for accuracy.

PH Joint Favorable Subst.

-LCO sHB6604 / File No.

73 4 sHB6604 File No.

73 The following Fiscal Impact Statement and Bill Analysis are prepared for the benefit of the members of the General Assembly, solely for purposes of information, summarization and explanation and do not represent the intent of the General Assembly or either chamber thereof for any purpose.

In general, fiscal impacts are based upon a variety of informational sources, including the analyst’s professional knowledge.

Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.

OFA Fiscal Note State Impact:

Agency Affected Fund-Effect FY 24 $ FY 25 $ Public Health, Dept.

GF - Cost 381,387 391,663 State Comptroller - Fringe Benefits GF - Cost 29,742 35,691 Note:

GF=General Fund Municipal Impact:

None Explanation This bill, which expands the scope of the Department of Public Health’s (DPH) Breast and Cervical Cancer Early Detection and Treatment Program to include lung cancer screening and referral services by 10/1/23, results in a cost to DPH of $381,387 in FY 24 and $391,663 in FY 25 and a cost to the Office of State Comptroller – Fringe Benefits of $29,742 in FY 24 and $35,691 in FY 25.

The costs to DPH include Health Program Associate (HPA) of $69,459 in FY 24 (partial year) and $83,351 in FY 25 (annualized).

Fringe benefits for this position are $29,742 in FY 24 and $35,691 in FY 25 to the Office of State Comptroller – Fringe Benefits.

The HPA would be responsible for lung cancer screening quality assurance, program data evaluation, and fiscal monitoring.

Additional costs to DPH include a one-time equipment cost of $3,616 in FY 24, and on-going other expenses in both fiscal years totaling $308,312 in FY 24 and FY 25 for:

(1) an electronic data entry system for 21 hospitals in 5 different health systems to access ($57,492), (2) Community Health The fringe benefit costs for most state employees are budgeted centrally in accounts administered by the Comptroller.

The estimated active employee fringe benefit cost associated with most personnel changes is 42.82% of payroll in FY 24.

sHB6604 / File No.

73 5 sHB6604 File No.

73 Navigators in each of the health systems ($50,000 each) responsible for outreach, education, enrollment, navigation and screening of patients (3) mileage reimbursement ($570), and (4) general office supplies ($250).

The Out Years The annualized ongoing fiscal impact identified above would continue into the future subject to inflation.